Have been building up their balance sheet to complete their final trials. Are now approaching a critical time. Feels the company can start to look better from here.
They are risk model on bile tax turned negative a couple of months ago so they sold their holdings. Well-run and has an interesting product. They are in the process of being listed in the US. Wait for some strength in that sector.
When a biotech finds the right thing, the stock can jump like crazy. This company just had a 1 for 10 reverse split. 90% of companies that do a reverse split are still down one year later.
Your Watchlist
Add stocks to watchlist to monitor them daily and get important alerts.